Again, like for TTS, the use of IVIG in SJS could be considered since IVIG interact with the effector function of T cells, B cells, and monocytes blocking the interaction of Fas (CD95) with its ligand (FasL, CD95L) (39). The gene discussed is FASLG; the disease is Schwartz-Jampel syndrome.